Luchmann, Dietmar
Jecklin, Sascha
Cavalcanti, Nicola A.
Laux, Christoph J.
Massalimova, Aidana
Esfandiari, Hooman
Farshad, Mazda
Fürnstahl, Philipp
Funding for this research was provided by:
Monique De La Cour Foundation, Switerland
Internal Funding of the University of Zurich, Medical Faculty
Article History
Received: 13 September 2024
Accepted: 11 November 2024
First Online: 19 November 2024
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the local ethical committee (Kantonale Ethikkommission Zurich BASEC No. 2021 − 01083). Clinical trial number: not applicable.
: All human specimens were sourced from Science Care (Phoenix, Arizona). Body donors and their next of kin agreed by written informed consent to the postmortem use of their body for research purposes.
: All authors have approved the manuscript and agree with its submission to BMC Musculoskeletal Disorders. Written informed consent was obtained from all body donors and their next of kin.
: The authors declare the following personal relationships which may be considered as potential competing interests: Mazda Farshad reports a relationship with X23D AG that includes: equity or stocks. Hooman Esfandiari and Philipp Fürnstahl report a relationship with X23D AG that includes: board membership and equity or stocks. Hooman Esfandiari, Philipp Fürnstahl and Mazda Farshad have a patent #WO2023156608A1 pending to University of Zurich. Hooman Esfandiari, Philipp Fürnstahl, Mazda Farshad, and Sascha Jecklin have a patent ”A computer-implemented method, device, system and computer program product for processing anatomic imaging data” pending to University of Zurich.